Selected research
Industry Growth & Trends
Global Actonel (Risedronic Acid) Industry Growth and Trends Forecast to 2032
Market perspective
The global Actonel (Risedronic Acid) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Actonel (Risedronic Acid) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Actonel (Risedronic Acid) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Actonel (Risedronic Acid) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Actonel (Risedronic Acid) include Takeda, Teva Pharmaceutical Industries, Sun Pharmaceutical Industries Ltd., Mylan, Warner Chilcott, Macleods Pharmaceuticals Ltd, Aurobindo Pharma, Apotex and Allergan plc (AbbVie Inc.), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Actonel (Risedronic Acid) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Actonel (Risedronic Acid) market size, estimates, and forecasts are presented in terms of sales volume (k tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Actonel (Risedronic Acid) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Actonel (Risedronic Acid).
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Actonel (Risedronic Acid) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Actonel (Risedronic Acid) Market by Company
Takeda
Teva Pharmaceutical Industries
Sun Pharmaceutical Industries Ltd.
Mylan
Warner Chilcott
Macleods Pharmaceuticals Ltd
Aurobindo Pharma
Apotex
Allergan plc (AbbVie Inc.)
Actonel (Risedronic Acid) Segment by Type
5 mg
35 mg
75 mg
150 mg
Actonel (Risedronic Acid) Segment by Application
Paget's Disease of Bone
Osteoporosis
Others
Actonel (Risedronic Acid) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Actonel (Risedronic Acid) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Actonel (Risedronic Acid) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Actonel (Risedronic Acid).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Actonel (Risedronic Acid) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Actonel (Risedronic Acid) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 5 mg
- 35 mg
- 75 mg
- 150 mg
Applications
- Paget's Disease of Bone
- Osteoporosis
- Others
Companies covered
- Takeda
- Teva Pharmaceutical Industries
- Sun Pharmaceutical Industries Ltd.
- Mylan
- Warner Chilcott
- Macleods Pharmaceuticals Ltd
- Aurobindo Pharma
- Apotex
- Allergan plc (AbbVie Inc.)
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Actonel (Risedronic Acid) Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Actonel (Risedronic Acid) Sales Estimates and Forecasts (2021-2032)
- 1.3 Actonel (Risedronic Acid) Market by Type
- 1.3.1 5 mg
- 1.3.2 35 mg
- 1.3.3 75 mg
- 1.3.4 150 mg
- 1.4 Global Actonel (Risedronic Acid) Market Size by Type
- 1.4.1 Global Actonel (Risedronic Acid) Market Size Overview by Type (2021-2032)
- 1.4.2 Global Actonel (Risedronic Acid) Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Actonel (Risedronic Acid) Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Actonel (Risedronic Acid) Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Actonel (Risedronic Acid) Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Actonel (Risedronic Acid) Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Actonel (Risedronic Acid) Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Actonel (Risedronic Acid) Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Actonel (Risedronic Acid) Industry Trends
- 2.2 Actonel (Risedronic Acid) Industry Drivers
- 2.3 Actonel (Risedronic Acid) Industry Opportunities and Challenges
- 2.4 Actonel (Risedronic Acid) Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Actonel (Risedronic Acid) Revenue (2021-2026)
- 3.2 Global Top Players by Actonel (Risedronic Acid) Sales (2021-2026)
- 3.3 Global Top Players by Actonel (Risedronic Acid) Price (2021-2026)
- 3.4 Global Actonel (Risedronic Acid) Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Actonel (Risedronic Acid) Major Company Production Sites & Headquarters
- 3.6 Global Actonel (Risedronic Acid) Company, Product Type & Application
- 3.7 Global Actonel (Risedronic Acid) Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Actonel (Risedronic Acid) Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Actonel (Risedronic Acid) Players Market Share by Revenue in 2025
- 3.8.3 2025 Actonel (Risedronic Acid) Tier 1, Tier 2, and Tier 3
4 Actonel (Risedronic Acid) Regional Status and Outlook
- 4.1 Global Actonel (Risedronic Acid) Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Actonel (Risedronic Acid) Historic Market Size by Region
- 4.2.1 Global Actonel (Risedronic Acid) Sales in Volume by Region (2021-2026)
- 4.2.2 Global Actonel (Risedronic Acid) Sales in Value by Region (2021-2026)
- 4.2.3 Global Actonel (Risedronic Acid) Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Actonel (Risedronic Acid) Forecasted Market Size by Region
- 4.3.1 Global Actonel (Risedronic Acid) Sales in Volume by Region (2027-2032)
- 4.3.2 Global Actonel (Risedronic Acid) Sales in Value by Region (2027-2032)
- 4.3.3 Global Actonel (Risedronic Acid) Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Actonel (Risedronic Acid) by Application
- 5.1 Actonel (Risedronic Acid) Market by Application
- 5.1.1 Paget's Disease of Bone
- 5.1.2 Osteoporosis
- 5.1.3 Others
- 5.2 Global Actonel (Risedronic Acid) Market Size by Application
- 5.2.1 Global Actonel (Risedronic Acid) Market Size Overview by Application (2021-2032)
- 5.2.2 Global Actonel (Risedronic Acid) Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Actonel (Risedronic Acid) Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Actonel (Risedronic Acid) Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Actonel (Risedronic Acid) Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Actonel (Risedronic Acid) Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Actonel (Risedronic Acid) Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Actonel (Risedronic Acid) Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Takeda
- 6.1.1 Takeda Company Information
- 6.1.2 Takeda Business Overview
- 6.1.3 Takeda Actonel (Risedronic Acid) Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Takeda Actonel (Risedronic Acid) Product Portfolio
- 6.1.5 Takeda Recent Developments
- 6.2 Teva Pharmaceutical Industries
- 6.2.1 Teva Pharmaceutical Industries Company Information
- 6.2.2 Teva Pharmaceutical Industries Business Overview
- 6.2.3 Teva Pharmaceutical Industries Actonel (Risedronic Acid) Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Teva Pharmaceutical Industries Actonel (Risedronic Acid) Product Portfolio
- 6.2.5 Teva Pharmaceutical Industries Recent Developments
- 6.3 Sun Pharmaceutical Industries Ltd.
- 6.3.1 Sun Pharmaceutical Industries Ltd. Company Information
- 6.3.2 Sun Pharmaceutical Industries Ltd. Business Overview
- 6.3.3 Sun Pharmaceutical Industries Ltd. Actonel (Risedronic Acid) Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Sun Pharmaceutical Industries Ltd. Actonel (Risedronic Acid) Product Portfolio
- 6.3.5 Sun Pharmaceutical Industries Ltd. Recent Developments
- 6.4 Mylan
- 6.4.1 Mylan Company Information
- 6.4.2 Mylan Business Overview
- 6.4.3 Mylan Actonel (Risedronic Acid) Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Mylan Actonel (Risedronic Acid) Product Portfolio
- 6.4.5 Mylan Recent Developments
- 6.5 Warner Chilcott
- 6.5.1 Warner Chilcott Company Information
- 6.5.2 Warner Chilcott Business Overview
- 6.5.3 Warner Chilcott Actonel (Risedronic Acid) Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Warner Chilcott Actonel (Risedronic Acid) Product Portfolio
- 6.5.5 Warner Chilcott Recent Developments
- 6.6 Macleods Pharmaceuticals Ltd
- 6.6.1 Macleods Pharmaceuticals Ltd Company Information
- 6.6.2 Macleods Pharmaceuticals Ltd Business Overview
- 6.6.3 Macleods Pharmaceuticals Ltd Actonel (Risedronic Acid) Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Macleods Pharmaceuticals Ltd Actonel (Risedronic Acid) Product Portfolio
- 6.6.5 Macleods Pharmaceuticals Ltd Recent Developments
- 6.7 Aurobindo Pharma
- 6.7.1 Aurobindo Pharma Company Information
- 6.7.2 Aurobindo Pharma Business Overview
- 6.7.3 Aurobindo Pharma Actonel (Risedronic Acid) Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Aurobindo Pharma Actonel (Risedronic Acid) Product Portfolio
- 6.7.5 Aurobindo Pharma Recent Developments
- 6.8 Apotex
- 6.8.1 Apotex Company Information
- 6.8.2 Apotex Business Overview
- 6.8.3 Apotex Actonel (Risedronic Acid) Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Apotex Actonel (Risedronic Acid) Product Portfolio
- 6.8.5 Apotex Recent Developments
- 6.9 Allergan plc (AbbVie Inc.)
- 6.9.1 Allergan plc (AbbVie Inc.) Company Information
- 6.9.2 Allergan plc (AbbVie Inc.) Business Overview
- 6.9.3 Allergan plc (AbbVie Inc.) Actonel (Risedronic Acid) Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Allergan plc (AbbVie Inc.) Actonel (Risedronic Acid) Product Portfolio
- 6.9.5 Allergan plc (AbbVie Inc.) Recent Developments
7 North America by Country
- 7.1 North America Actonel (Risedronic Acid) Sales by Country
- 7.1.1 North America Actonel (Risedronic Acid) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Actonel (Risedronic Acid) Sales by Country (2021-2026)
- 7.1.3 North America Actonel (Risedronic Acid) Sales Forecast by Country (2027-2032)
- 7.2 North America Actonel (Risedronic Acid) Market Size by Country
- 7.2.1 North America Actonel (Risedronic Acid) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Actonel (Risedronic Acid) Market Size by Country (2021-2026)
- 7.2.3 North America Actonel (Risedronic Acid) Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Actonel (Risedronic Acid) Sales by Country
- 8.1.1 Europe Actonel (Risedronic Acid) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Actonel (Risedronic Acid) Sales by Country (2021-2026)
- 8.1.3 Europe Actonel (Risedronic Acid) Sales Forecast by Country (2027-2032)
- 8.2 Europe Actonel (Risedronic Acid) Market Size by Country
- 8.2.1 Europe Actonel (Risedronic Acid) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Actonel (Risedronic Acid) Market Size by Country (2021-2026)
- 8.2.3 Europe Actonel (Risedronic Acid) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Actonel (Risedronic Acid) Sales by Country
- 9.1.1 Asia-Pacific Actonel (Risedronic Acid) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Actonel (Risedronic Acid) Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Actonel (Risedronic Acid) Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Actonel (Risedronic Acid) Market Size by Country
- 9.2.1 Asia-Pacific Actonel (Risedronic Acid) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Actonel (Risedronic Acid) Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Actonel (Risedronic Acid) Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Actonel (Risedronic Acid) Sales by Country
- 10.1.1 South America Actonel (Risedronic Acid) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Actonel (Risedronic Acid) Sales by Country (2021-2026)
- 10.1.3 South America Actonel (Risedronic Acid) Sales Forecast by Country (2027-2032)
- 10.2 South America Actonel (Risedronic Acid) Market Size by Country
- 10.2.1 South America Actonel (Risedronic Acid) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Actonel (Risedronic Acid) Market Size by Country (2021-2026)
- 10.2.3 South America Actonel (Risedronic Acid) Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Actonel (Risedronic Acid) Sales by Country
- 11.1.1 Middle East and Africa Actonel (Risedronic Acid) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Actonel (Risedronic Acid) Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Actonel (Risedronic Acid) Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Actonel (Risedronic Acid) Market Size by Country
- 11.2.1 Middle East and Africa Actonel (Risedronic Acid) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Actonel (Risedronic Acid) Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Actonel (Risedronic Acid) Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Actonel (Risedronic Acid) Value Chain Analysis
- 12.1.1 Actonel (Risedronic Acid) Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Actonel (Risedronic Acid) Production Mode & Process
- 12.2 Actonel (Risedronic Acid) Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Actonel (Risedronic Acid) Distributors
- 12.2.3 Actonel (Risedronic Acid) Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst